{"DataElement":{"publicId":"7532267","version":"1","preferredName":"Laboratory Procedure Antibody or Titer Name","preferredDefinition":"The name of the autoimmune antibody or titer laboratory test.","longName":"LAB_AUTOIMM_AB_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"7527865","version":"1","preferredName":"Laboratory Procedure Antibody Or Titer Performed","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A protein made by plasma cells (a type of white blood cell) in response to an antigen (a substance that causes the body to make a specific immune response). Each antibody can bind to only one specific antigen. The purpose of this binding is to help destroy the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent._Executed and carried through to completion.","longName":"2543047v1.0:7527863v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7527863","version":"1","preferredName":"Antibody Or Titer Performed","preferredDefinition":"A protein made by plasma cells (a type of white blood cell) in response to an antigen (a substance that causes the body to make a specific immune response). Each antibody can bind to only one specific antigen. The purpose of this binding is to help destroy the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent.:Executed and carried through to completion.","longName":"C16295:C37998:C67454:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Titer","conceptCode":"C67454","definition":"Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B620BA15-2C60-1F1B-E053-4EBD850AAC66","latestVersionIndicator":"Yes","beginDate":"2020-12-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-10","modifiedBy":"ONEDATA","dateModified":"2020-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B620BA15-2C71-1F1B-E053-4EBD850AAC66","latestVersionIndicator":"Yes","beginDate":"2020-12-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-10","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeDescription":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7531532","version":"1","preferredName":"Autoimmune Antibody or Titer Measurement Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"AB_MEAS_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"TTIgA","valueDescription":"Tissue Transglutaminase Antibody Measurement","ValueMeaning":{"publicId":"7531534","version":"1","preferredName":"Tissue Transglutaminase Antibody Measurement","longName":"7531534","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tissue Transglutaminase Antibody Measurement","conceptCode":"C163969","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6339967-04B2-4205-E053-4EBD850AA684","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-04CB-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Thyroid stimulating hormone receptor","valueDescription":"Thyroid Stimulating Hormone Receptor Antibody Measurement","ValueMeaning":{"publicId":"6404055","version":"1","preferredName":"Thyroid Stimulating Hormone Receptor Antibody Measurement","longName":"6404055","preferredDefinition":"The determination of the amount of thyroid stimulating hormone receptor antibody present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Stimulating Hormone Receptor Antibody Measurement","conceptCode":"C122158","definition":"The determination of the amount of thyroid stimulating hormone receptor antibody present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73E02573-AC37-0FF7-E053-F662850AE77D","latestVersionIndicator":"Yes","beginDate":"2018-08-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-20","modifiedBy":"ONEDATA","dateModified":"2018-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-04DF-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Islet cell /GAD 65 /insulin auto antibodies","valueDescription":"Glutamic Acid Decarboxylase Antibody Measurement Islet Cell 512 Antibody Measurement Insulin Antibody Measurement","ValueMeaning":{"publicId":"7531535","version":"1","preferredName":"Glutamic Acid Decarboxylase Antibody Measurement Islet Cell 512 Antibody Measurement Insulin Antibody Measurement","longName":"7531535","preferredDefinition":"The determination of the amount of glutamic acid decarboxylase antibody present in a sample.: The determination of the amount of islet cell 512 antibody present in a sample.: The determination of the amount of insulin antibody in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glutamic Acid Decarboxylase Antibody Measurement","conceptCode":"C96653","definition":"The determination of the amount of glutamic acid decarboxylase antibody present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Islet Cell 512 Antibody Measurement","conceptCode":"C81985","definition":"The determination of the amount of islet cell 512 antibody present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Insulin Antibody Measurement","conceptCode":"C119287","definition":"The determination of the amount of insulin antibody in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6339967-04EE-4205-E053-4EBD850AA684","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-0507-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Anti-thyroglobulin","valueDescription":"Anti Thyroglobulin Antibody Measurement","ValueMeaning":{"publicId":"7531536","version":"1","preferredName":"Anti Thyroglobulin Antibody Measurement","longName":"7531536v1.00","preferredDefinition":"The determination of the amount of thyroid antithyroglobulin antibodies present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Antithyroglobulin Antibody Measurement","conceptCode":"C81992","definition":"The determination of the amount of thyroid antithyroglobulin antibodies present in a sample.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6339967-0511-4205-E053-4EBD850AA684","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-052A-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Anti-mitochondrial","valueDescription":"Antimitochondrial Antibody Measurement","ValueMeaning":{"publicId":"6404245","version":"1","preferredName":"Antimitochondrial Antibody Measurement","longName":"6404245","preferredDefinition":"The determination of the amount of antimitochondrial antibodies present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antimitochondrial Antibody Measurement","conceptCode":"C81975","definition":"The determination of the amount of antimitochondrial antibodies present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73E12EFD-8E32-6B1F-E053-F662850AB9A6","latestVersionIndicator":"Yes","beginDate":"2018-08-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-20","modifiedBy":"ONEDATA","dateModified":"2018-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-053E-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Anti-granulocyte","valueDescription":"Anti Granulocyte Antibody Measurement","ValueMeaning":{"publicId":"7531537","version":"1","preferredName":"Anti Granulocyte Antibody Measurement","longName":"7531537v1.00","preferredDefinition":"A measurement of the total amount of anti-granulocyte antibody in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granulocyte Antibody Measurement","conceptCode":"C176762","definition":"A measurement of the total amount of anti-granulocyte antibody in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6339967-0549-4205-E053-4EBD850AA684","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-0562-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Anti TPO","valueDescription":"Thyroid Peroxidase Antibody Measurement","ValueMeaning":{"publicId":"7531538","version":"1","preferredName":"Thyroid Peroxidase Antibody Measurement","longName":"7531538v1.00","preferredDefinition":"The determination of the amount of thyroperoxidase antibody present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroperoxidase Antibody Measurement","conceptCode":"C96638","definition":"The determination of the amount of thyroperoxidase antibody present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6339967-056C-4205-E053-4EBD850AA684","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-0585-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Anti smooth muscle","valueDescription":"Smooth Muscle Antibody Measurement","ValueMeaning":{"publicId":"6407687","version":"1","preferredName":"Smooth Muscle Antibody Measurement","longName":"6407687","preferredDefinition":"The determination of the amount of smooth muscle antibody present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Smooth Muscle Antibody Measurement","conceptCode":"C111317","definition":"The determination of the amount of smooth muscle antibody present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3DCAA-5136-2714-E053-F662850A304C","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-21","modifiedBy":"ONEDATA_WA","dateModified":"2024-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-0599-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Anti platelet","valueDescription":"Antiplatelet Antibody Measurement","ValueMeaning":{"publicId":"7531539","version":"1","preferredName":"Antiplatelet Antibody Measurement","longName":"7531539v1.00","preferredDefinition":"A measurement of the total amount of anti-platelet antibody in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Platelet Antibody Measurement","conceptCode":"C176760","definition":"A measurement of the total amount of anti-platelet antibody in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6339967-05A4-4205-E053-4EBD850AA684","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-05BD-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Anti nuclear pore (gp120)","valueDescription":"Anti Nuclear Pore gp120 Antibody Measurement","ValueMeaning":{"publicId":"7531540","version":"1","preferredName":"Anti Nuclear Pore gp120 Antibody Measurement","longName":"7531540v1.00","preferredDefinition":"A measurement of the nuclear pore glycoprotein 120-specific antibodies in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nuclear Pore gp120 Antibody Measurement","conceptCode":"C176759","definition":"A measurement of the nuclear pore glycoprotein 120-specific antibodies in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6339967-05C7-4205-E053-4EBD850AA684","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-05E0-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Anti nuclear dot (sp100)","valueDescription":"Anti SP100 Antibody Measurement","ValueMeaning":{"publicId":"7531541","version":"1","preferredName":"Anti SP100 Antibody Measurement","longName":"7531541v1.00","preferredDefinition":"A measurement of SP100-specific antibodies in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SP100 Antibody Measurement","conceptCode":"C176758","definition":"A measurement of SP100-specific antibodies in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6339967-05EA-4205-E053-4EBD850AA684","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-0603-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Anti Liver-Kidney microsomal","valueDescription":"Anti-KLM (Liver Kidney Microsomal) Antibody","ValueMeaning":{"publicId":"3447111","version":"1","preferredName":"Anti-KLM (Liver Kidney Microsomal) Antibody","longName":"3447111","preferredDefinition":"The determination of the amount of liver kidney microsomal type 1 antibody present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Kidney Microsomal Type 1 Antibody Measurement","conceptCode":"C96683","definition":"The determination of the amount of liver kidney microsomal type 1 antibody present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0E27EF-C605-7856-E040-BB89AD43436A","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-02","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-0617-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"Anti centromere","valueDescription":"Centromere IgG Antibody Measurement","ValueMeaning":{"publicId":"6409065","version":"1","preferredName":"Centromere IgG Antibody Measurement","longName":"6409065","preferredDefinition":"The determination of the amount of centromere IgG antibody present in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Centromere IgG Antibody Measurement","conceptCode":"C122111","definition":"The determination of the amount of centromere IgG antibody present in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"740424EF-D936-4F7D-E053-F662850AB02A","latestVersionIndicator":"Yes","beginDate":"2018-08-22","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-22","modifiedBy":"ONEDATA","dateModified":"2018-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-062C-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"},{"value":"ANCA/AntiGBM/AntiC1q","valueDescription":"GBM Antigens and Alloantigens Immunotherapeutic Vaccine Antineutrophil Cytoplasmic Antibody Complement C1q Antibody Measurement","ValueMeaning":{"publicId":"7531543","version":"1","preferredName":"GBM Antigens and Alloantigens Immunotherapeutic Vaccine Antineutrophil Cytoplasmic Antibody Complement C1q Antibody Measurement","longName":"7531543","preferredDefinition":"An orally bioavailable, immunotherapeutic vaccine composed of hydrolyzed and formulated glioblastoma multiforme (GBM) antigens and alloantigens derived from a pool of patients' cancer cells in the blood and samples of tumor tissues, with potential immunomodulating and antineoplastic activities. Upon oral administration of the GBM antigens and alloantigens immunotherapeutic vaccine, the GBM antigens and alloantigens may stimulate the host immune system via antigen-presenting cells (APCs) lining the gut to mount an immune response against tumor cells expressing these antigens. This may lead to tumor cell death.: An autoantibody that recognizes antigens found in the cytoplasm of neutrophils.: The determination of the amount of complement C1q antibody present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GBM Antigens and Alloantigens Immunotherapeutic Vaccine","conceptCode":"C172199","definition":"An orally bioavailable, immunotherapeutic vaccine composed of hydrolyzed and formulated glioblastoma multiforme (GBM) antigens and alloantigens derived from a pool of patients' cancer cells in the blood and samples of tumor tissues, with potential immunomodulating and antineoplastic activities. Upon oral administration of the GBM antigens and alloantigens immunotherapeutic vaccine, the GBM antigens and alloantigens may stimulate the host immune system via antigen-presenting cells (APCs) lining the gut to mount an immune response against tumor cells expressing these antigens. This may lead to tumor cell death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Antineutrophil Cytoplasmic Antibody","conceptCode":"C129400","definition":"An autoantibody that recognizes antigens found in the cytoplasm of neutrophils.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complement C1q Antibody Measurement","conceptCode":"C80173","definition":"The determination of the amount of complement C1q antibody present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6339967-063C-4205-E053-4EBD850AA684","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6339967-0655-4205-E053-4EBD850AA684","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6339967-0499-4205-E053-4EBD850AA684","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":"2023.8.21 Added missing PV concepts. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Antibody present/titer","type":"Preferred Question Text","description":"Antibody present/titer","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6827FBB-C046-5DC8-E053-4EBD850A4A38","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeDescription":"Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}